A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease.

Sayki Arslan, Muyesser; Turhan, Sibel; Dincer, Irem; Mizrak, Dilsa; Corapcioglu, Demet; Idilman, Ramazan

Sayki Arslan, Muyesser; Turhan, Sibel; Dincer, Irem; Mizrak, Dilsa; Corapcioglu, Demet; Idilman, Ramazan.

Afiliación

Sayki Arslan M; Department of Internal Medicine, Ankara University, School of Medicine, Yeni Ziraat Mah. 656. sok. 22/4. Altindag, Ankara, Turkey.
Turhan S; Department of Cardiology, Ankara University, School of Medicine, Ankara, Turkey.
Dincer I; Department of Cardiology, Ankara University, School of Medicine, Ankara, Turkey.
Mizrak D; Department of Internal Medicine, Ankara University, School of Medicine, Yeni Ziraat Mah. 656. sok. 22/4. Altindag, Ankara, Turkey.
Corapcioglu D; Department of Endocrinology and Metabolism, Ankara University, School of Medicine, Ankara, Turkey.
Idilman R; Department of Gastroenterology, Ankara University, School of Medicine, Ankara, Turkey.

Diabetol Metab Syndr ; 6: 109, 2014.

Article en En | MEDLINE | ID: mdl-25960770

Palabras clave

Asymmetric dimethylarginine; Cardiovascular risk; Endothelial function; Metabolic syndrome; Non-alcoholic fatty liver disease

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Diabetol Metab Syndr Año: 2014 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google